GH1 and neoplasm: In this regard, we found that patients with GH lower than 6 ng/ml at diagnosis had a milder acromegaly phenotype, not just biochemically but also regarding tumor burden (smaller and less extrasellar tumor), and more patients achieve disease control with SRL (27).